Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Better Plant Sciences Inc C.PLNT.X

Industrials
Better Plant Sciences Inc. is a Canada-based company. The Company is reviewing potential new business opportunities and acquisitions.


CSE:PLNT.X - Post by User

Better Plant Sciences Inc > SIGNS PSILOCYBIN SUPPLY AGREEMENT FOR CLINICAL TRIALS
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Post by Viralstocks1on Sep 30, 2020 1:58pm
170 Views
Post# 31642743

SIGNS PSILOCYBIN SUPPLY AGREEMENT FOR CLINICAL TRIALS

SIGNS PSILOCYBIN SUPPLY AGREEMENT FOR CLINICAL TRIALS
News Release (29-09-20): Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) BETTER PLANT SCIENCES SUBSIDIARY NEONMIND SIGNS PSILOCYBIN SUPPLY AGREEMENT FOR CLINICAL TRIALS.
READ HERE: https://betterplantsciences.com/press-release/better-plant-sciences-subsidiary-neonmind-signs-psilocybin-supply-agreement-for-clinical-trials/

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities